Rabbit B cell antibody discovery

Expand what you can discover

MindWalk is a leader in rabbit B cell antibody discovery, with decades of specialized experience behind our proprietary B cell Select® platform. We combine the breadth of the rabbit immune repertoire with function-first screening and native heavy/light-chain recovery. Biological data and AI extend discovery with deeper insight into candidate function, specificity, and potential.

For therapeutics, anti-idiotypic and anti-drug antibodies, diagnostics, and research applications such as IHC/ICC or flow cytometry reagents

 

200+

B cell Select® programs completed 

>98% antibody discovery success*

*Success refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.

35+ years 

antibody discovery expertise

Find functional candidates early.

B cell Select® is designed to bring functional relevance into rabbit antibody discovery early, helping teams move beyond binding alone and focus on the candidates aligned with program goals.

 

The advantage is in the combination:

+   Deep access to diverse, in vivo-matured immune responses 
+   Antigen-specific memory B cell enrichment to recover relevant candidates 
+   Function-first screening early in discovery 
+   Native heavy/light chain pair recovery
+   A broader, functionally resolved candidate landscape

Proprietary B cell Select® is designed to capture biological diversity at the onset and translate it into relevant, functional candidates.

Integrated data and AI, built around your program needs

With the flexibility to integrate LensAI™ and ReefIQ™ around each program, teams can extend B cell Select® with fit-for-purpose analytics, connected program data, and biological context for deeper candidate evaluation and advancement decisions.

See more before you advance

Rabbit expands the search space, with the flexibility to add integrated data and AI for deeper candidate insight, building on each discovery to reveal more of what the repertoire can offer.

TDL workflow_for Bcell-Sep-16-2026-04-39-53-4310-PM
ReefIQ™ Biological data substrate

Connects discovery data and enriches it with biological context across sequence, structure, function, mechanism, pathways, literature, and experimental evidence.

LensAI™ Bio-Native analytical AI applications

Fit-for-purpose applications evaluate candidate function, developability, immunogenicity, epitope characteristics, and other advancement considerations.

Rabbit antibody discovery across applications

The discovery strategy can be customized around program goals.

Therapeutic antibodies  

Rabbit antibody discovery for difficult targets, differentiated epitopes, functional selection, humanization, and optimization.

Research

Antibodies developed around target and application-specific performance requirements such as IHC/ICC or flow cytometry reagents

Rabbit-derived antibodies in preclinical and clinical development

OncoResponse highlight

MindWalk’s B cell Select® platform contributed to the discovery of OR502 and OR641, two rabbit-derived oncology programs advanced by OncoResponse.

OR502
Humanized rabbit-derived anti-LILRB2 antibody in active Phase 1/2 clinical development for advanced solid tumors.

OR641
Humanized rabbit-derived dual LILRB1/LILRB2 antagonist in preclinical/IND-enabling development.

Explore published research and publicly disclosed programs →

These programs illustrate a path from rabbit B-cell discovery into downstream therapeutic development. Additional client programs have advanced but are not publicly disclosed. MindWalk’s contribution was at the discovery stage. OncoResponse owns and develops the programs.

Talk 1:1 with the team

MindWalk scientists and technologists work 1:1 with you to shape the program around the target, desired function, and program goals.

FAQs